论文部分内容阅读
用异搏定(Verapamil)治疗16例急性心肌梗死引起持续室上性快速性心律失常病人,治疗方法是静脉注射异搏定每分钟递增1 mg,总剂量为3～20 mg。治疗过程中连续监测病人心电图和血压。治疗终止的指标是:恢复窦性心律;心室率小于100次/分;肺毛细血管楔状压高于15mm汞柱;出现低血压;出现不能耐受的征象。治疗结果:8例心房扑动病人中7例转复为窦性心律,另8例心房纤颤病人1例转复为窦性心律;16例病人经治疗后心室率均小于100次/分。无明显的副作用。作者认为异搏定能有效的降低急性
Verapamil was used to treat patients with persistent supraventricular tachyarrhythmia treated with 16 patients with acute myocardial infarction treated by intravenous injection of verapamil at 1 mg per minute for a total dose of 3 to 20 mg. Continuous monitoring of patient ECG and blood pressure during treatment. Treatment termination indicators are: to restore sinus rhythm; ventricular rate less than 100 beats / min; pulmonary capillary wedge pressure higher than 15mm Hg; hypotension; intolerance signs. Treatment outcome: 8 cases of atrial flutter in 7 patients converted to sinus rhythm, and the other 8 cases of atrial fibrillation patients converted to sinus rhythm; 16 patients after treatment, the ventricular rate was less than 100 beats / min. No obvious side effects. The authors believe that verapamil can effectively reduce the acute